Oncotelic Therapeutics (OTLC) Return on Capital Employed [ROCE] (2011 - 2026)
Oncotelic Therapeutics' Return on Capital Employed [ROCE] was -1.04% in Q2 2026, up 46.05 percentage points from -47.10% a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Capital Employed [ROCE] at Oncotelic Therapeutics came in at -1.66%, up 37.44 percentage points from FY2024.
- Return on Capital Employed [ROCE] has now increased for four consecutive years, with a five-year change of +59.06 percentage points (FY2020 to FY2025).
- In earlier years, Return on Capital Employed [ROCE] was -39.10% in FY2024 (+1.04 pp), -40.14% in FY2023 (+34.98 pp), -75.12% in FY2022 (+36.40 pp) and -111.52% in FY2021 (-50.80 pp).
- The Q2 2026 figure marks the highest quarterly Return on Capital Employed [ROCE] in data going back to Q3 2011.
- Compared with a year earlier, Return on Capital Employed [ROCE] was higher in six of the last seven quarters, with an average year-over-year change of +17.95 percentage points.
- The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2023 (a gain of 143.66 percentage points); the worst was Q1 2022 (a drop of 109.61 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 16.76% |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 11.86% |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | -1.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.04% |
| Dec 31, 2025 | -1.66% |
| Sep 30, 2025 | -9.40% |
| Jun 30, 2025 | -47.10% |
| Mar 31, 2025 | -48.83% |
| Dec 31, 2024 | -47.49% |
| Sep 30, 2024 | -30.48% |
| Jun 30, 2024 | -2.64% |
| Mar 31, 2024 | -48.86% |
| Dec 31, 2023 | -49.33% |
| Sep 30, 2023 | -85.74% |
| Jun 30, 2023 | -78.34% |
| Mar 31, 2023 | -30.52% |
| Dec 31, 2022 | -45.74% |
| Sep 30, 2022 | -27.84% |
| Jun 30, 2022 | -50.63% |
| Mar 31, 2022 | -174.18% |
| Dec 31, 2021 | -114.84% |
| Sep 30, 2021 | -126.51% |
| Jun 30, 2021 | -110.56% |
API Access
Oncotelic Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();